These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13878777)

  • 21. [Studies on the properdin system in hemoblastosis].
    Reissmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):1-9. PubMed ID: 4157878
    [No Abstract]   [Full Text] [Related]  

  • 22. [Properdin level and antibody production in the rabbit during immunization with Mycobacterium tuberculosis and Salmonella typhosa].
    HEYMANN G; WAHLIG H
    Z Immun exp ther; 1959 Jul; 118():57-72. PubMed ID: 14401639
    [No Abstract]   [Full Text] [Related]  

  • 23. [Yeast therapy and blood properdin in cancerology (preliminary brief notes)].
    CAPRIA F
    Gazz Med Ital; 1961 Oct; 120():394-6. PubMed ID: 13876381
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on the properdin system of the rabbit. (IV) Relationship of properdin titer and antibody-forming activity].
    YAMAMASU N
    Nihon Saikingaku Zasshi; 1961 Dec; 16():1084-9. PubMed ID: 14008820
    [No Abstract]   [Full Text] [Related]  

  • 25. The properdin system in tumorous disease. Part VI. Influence of the properdin fraction on the cancerogenic activity of chicken tumour virus B77.
    SMIDA J; HOLUBEK V; ORAVEC C; THURZO V
    Neoplasma; 1960; 7():26-30. PubMed ID: 13831804
    [No Abstract]   [Full Text] [Related]  

  • 26. INVESTIGATIONS OF THE IMMUNOLOGICAL REACTIVITY IN HAEMOBLASTOSES. IV. THE BACTERICIDAL PROPERTIES OF THE SERUM AGAINST GRAM-POSITIVE MICROBES IN PATIENTS SUFFERING FROM LEUKAEMIA, MALIGNANT LYMPHOMA, MYELOMA, AND MYELOFIBROSIS.
    LIBANSKY J; JEZKOVA Z
    Neoplasma; 1964; 11():71-87. PubMed ID: 14116776
    [No Abstract]   [Full Text] [Related]  

  • 27. [THE BEHAVIOR OF CIRCULATING ANTIBODIES AND PROPERDIN FOLLOWING SENSITIZATION WITH HOMOLOGOUS TISSUE ANTIGENS].
    SCHEIFFARTH F; WARNATZ H; FRENGER W; HALFAR I; TYMPNER KD
    Z Gesamte Exp Med; 1964 Feb; 138():81-91. PubMed ID: 14161934
    [No Abstract]   [Full Text] [Related]  

  • 28. [Natural resistence-studies on properdin].
    ADAMSON CA; HEIWINKEL H
    Sven Lakartidn; 1960 Apr; 57():1190-6. PubMed ID: 13791833
    [No Abstract]   [Full Text] [Related]  

  • 29. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. IV. RELATION OF SERUM COMPLEMENT ACTIVITY AND PROPERDIN LEVEL OF NORMAL ALBINO RATS TO STREPTOMYCIN THERAPY AND DIET.
    SEN R; MATHUR PD; MAJUMDAR AC
    Ann Biochem Exp Med; 1963 Dec; 23():577-82. PubMed ID: 14154202
    [No Abstract]   [Full Text] [Related]  

  • 30. [Properdin level in proliferative diseases of the hematopoietic system].
    Pietruska Z
    Pol Arch Med Wewn; 1968 Jun; 40(6):711-5. PubMed ID: 5244787
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of the bactericidal activity of the properdin system by zymosan and other properdin binding agents.
    WARDLAW AC; PILLEMER L
    J Immunol; 1959 Apr; 82(4):313-8. PubMed ID: 13641665
    [No Abstract]   [Full Text] [Related]  

  • 32. Some observations in relation to the properdin system. I. A simple approach to the routine assay of properdin for its application to human sera.
    MAJUMDAR AC; SEN R; MUKERJI B
    Ann Biochem Exp Med; 1962 Aug; 22():197-204. PubMed ID: 14468641
    [No Abstract]   [Full Text] [Related]  

  • 33. The rabbit properdin system: I. Identification of a new factor and purification of rabbit properdin.
    Naff GB; Hedrick SW; Ratnoff WD; Novak MA; Smith MC; Steiner C; Todd EW
    J Immunol; 1980 Jun; 124(6):2625-31. PubMed ID: 6900053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PROPERDIN AND CANCER. II. CHANGES IN THE ASPECIFIC DEFENSES OF THE ORGANISM DURING ANTIBLASTIC CHEMOTHERAPY].
    DAMBROSIO F; SAGONE I
    Ann Ostet Ginecol; 1964 Mar; 86():211-46. PubMed ID: 14159238
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research on the natural immunity to infection by gramnegative bacteria. The properdin system as a mechanism of natural immunity. Relationship between nonspecific immune defenses and the properdin system. Note I].
    BO G
    Boll Ist Sieroter Milan; 1960; 39():151-62. PubMed ID: 13801764
    [No Abstract]   [Full Text] [Related]  

  • 36. SERUM PROPERDIN IN TUMOR-BEARING MICE. I. COMPARISON WITH NATURAL AND IMMUNE ANTIBODIES.
    SCHWARTZ EE; WINSTEN S
    Cancer Res; 1964 Jun; 24():825-9. PubMed ID: 14190547
    [No Abstract]   [Full Text] [Related]  

  • 37. The properdin system and immunity. XIV. The injection of human properdin into rabbits and the production of antibodies to properdin.
    HINZ CF; WEDGWOOD RJ; TODD EW; PILLEMER L
    J Immunol; 1960 Dec; 85():547-58. PubMed ID: 13714489
    [No Abstract]   [Full Text] [Related]  

  • 38. [Activity of the properdin system in acute hemorrhage].
    GARFUNKEL' ML; CHERTKOV IL
    Biull Eksp Biol Med; 1962 Aug; 54():26-30. PubMed ID: 13896951
    [No Abstract]   [Full Text] [Related]  

  • 39. [The "properdin system" and some stomatological diseases. VII. Relation between the serum properdin titer and malignant connective tissue neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():659-61. PubMed ID: 14480070
    [No Abstract]   [Full Text] [Related]  

  • 40. [The "properdin system" and some stomatological diseases. VI. Relation between the serum properdin titer and malignant epithelial neoplasms of the oral cavity. (Experimental contribution)].
    NITTI G; PETTINI PL
    Boll Soc Ital Biol Sper; 1962 Jul; 38():657-9. PubMed ID: 14480071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.